Actively Recruiting
Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2025-07-08
216
Participants Needed
2
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness of a self-posturotherapy technique on the clearance of residual kidney stone fragments three months after treatment for lower calyceal urinary stones. This study focuses on patients treated by extracorporeal lithotripsy (ECL) or retrograde flexible ureteroscopy (URSS) and aims to compare outcomes with standard care. The research is sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche and involves adult participants between 18 and 70 years old. Participants are randomly assigned to one of two groups: one receiving standard care according to recommendations plus a self-posturotherapy program, and the other receiving standard care alone. The self-posturotherapy is a behavioral intervention where patients perform a simplified posturotherapy protocol themselves, combining inclined positioning, percussion, and diuresis based on physiotherapy principles. The study does not use blinding and monitors participants over a three-month period. During the study, participants will be monitored to measure the stone-free rate at three months after treatment. Researchers will assess the presence of residual fragments using endoscopy and track adherence to the self-posturotherapy program. Safety and eligibility criteria are carefully monitored, including exclusion of patients with physical disabilities that prevent posturotherapy or those with medical conditions that may affect fragment clearance. The study duration extends to at least three months post-treatment to evaluate outcomes effectively.
CONDITIONS
Brief Title
Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has read and signed the consent form
- Candidate for intervention on a lower calyx stone smaller than 15mm by extracorporeal lithotripsy (LEC) or retrograde flexible ureteroscopy (URSS)
- Treated by LEC or URSS with presence of lower calyceal fragments observed by endoscopy
- No JJ stent currently in place (stent removal required before inclusion)
You will not qualify if you...
- Renal or ureteral malformations such as ureteral stenosis, pyelo-ureteral junction syndrome, horseshoe kidney, paracalyceal diverticulum, or pelvic kidney
- LEC session interrupted due to treatment intolerance
- Physical disability preventing self-posturotherapy, including spinal issues, morbid obesity, major gastroesophageal reflux, heart or respiratory failure
- Balance disorders preventing self-posturotherapy
- Legal protection status (guardianship, curatorship)
- Posturotherapy performed while wearing a JJ stent
- Posturotherapy performed by a third party
- Pregnant or breastfeeding
- Not affiliated with the French social security system
- Unable to provide informed consent due to dementia, psychosis, consciousness disorders, or language barrier
- Treatment affecting stone fragment clearance (e.g., beta blockers, diuretics)
- Participation in another therapeutic study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 months
Participants undergo standard care for lower calyx urinary stones with or without the self-posturotherapy program, which includes a simplified posturotherapy protocol performed by the participant.
Regular visits as per standard care and self-posturotherapy schedule
Duration - Up to 3 months
Participants are monitored to assess the elimination of residual stone fragments after treatment and self-posturotherapy.
1 to 2 follow-up visits
Trial Site Locations
Total: 2 locations
1
Hôpital Edouard Herriot -
Lyon, France, 69003
Actively Recruiting
2
Clinique La Croix du Sud
Quint-Fonsegrives, France, 31130
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here